Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Gainers

• Jeffs' Brands Ltd JFBR rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.
• Pliant Therapeutics, Inc. PLRX rose 48.8% to $33.49 in pre-market trading after the company announced data from the integris-IPF Phase 2a trial demonstrating bexotegrast 320 mg was well tolerated and achieved statistically significant FVC increase in patients with idiopathic pulmonary fibrosis.
• Helbiz, Inc. HLBZ rose 46.9% to $0.2993 in pre-market trading. Helbiz shares jumped 65% on Friday after the company said its Board of Directors has begun examining measures to address alleged illegal short selling of its stock.
• Allarity Therapeutics, Inc. ALLR rose 35.9% to $0.3450 in pre-market trading after gaining over 16% on Friday. Allarity Therapeutics announced adjournment of 2023 annual meeting of stockholders.
• Boxed, Inc. BOXD shares rose 34.3% to $0.6351 in pre-market trading after the company reported up to $20 million of new financing.
• Genius Group Limited GNS shares rose 22.2% to $3.96 in pre-market trading. Genius Group shares jumped 55% on Friday on continued strength after the company approved a plan to create an 'Illegal Trading Task Force.'
• WiSA Technologies, Inc. WISA rose 13.6% to $0.16 in pre-market trading after jumping 14% on Friday.
• Digital Brands Group, Inc. DBGI shares rose 10.6% to $2.85 in pre-market trading. DBG recently announced closing of $5.0 million private placement priced at-the-market under Nasdaq rules.
• Exela Technologies, Inc. XELA rose 7.4% to $0.0799 in pre-market trading. Exela Technologies recently signed a strategic partnership with Quintes Global.
• Tritium DCFC Limited DCFC rose 5.3% to $1.38 in pre-market trading. The company recently reported FY22 preliminary sales of $95 million to $102 million.

Losers

• Apexigen, Inc. APGN fell 12% to $1.76 in pre-market trading. Apexigen recently announced new Phase 2 data evaluating sotigalimab, its CD40 agonist antibody, at ASCO Gastrointestinal Cancers Symposium 2023.
• Cosmos Health Inc. COSM shares fell 10.8% to $4.75 in pre-market trading. Cosmos Health shares jumped 72% on Friday after the company updated the payment terms of its agreement to acquire ZipDoctor.
• Eargo, Inc. EAR fell 9.7% to $13.13 in pre-market trading after jumping 26% on Friday. The company recently effected a 1:20 reverse stock split.
• Ontrak, Inc. OTRK fell 8.5% to $0.97 in pre-market after declining around 12% on Friday. Ontrak recently announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
• TC Biopharm (Holdings) Plc TCBP fell 7.3% to $4.26 in pre-market trading after dropping around 12% on Friday. TC BioPharm recently received a notice of non-compliance with NASDAQ's Listing Rule 5550(b)(1).
• AppHarvest, Inc. APPH fell 6.2% to $1.52 in pre-market trading after jumping over 16% on Friday. AppHarvest said on January 11, that it received notice from Nasdaq that the company has not been in compliance with minimum bid price requirement.
• OceanPal Inc. OP shares dropped 6.1% to $0.8830 in pre-market trading. OceanPal recently regained compliance with Nasdaq minimum bid price requirement.
• Rigetti Computing, Inc. RGTI fell 5.9% to $0.84 in pre-market trading.
• NeuroSense Therapeutics Ltd. NRSN shares fell 4.5% to $1.70 in pre-market trading after dipping around 20% on Friday. NeuroSense Therapeutics recently reported final results from its Alzheimer's biomarker study.
• Grom Social Enterprises, Inc. GROM fell 4.1% to $1.65 in pre-market trading after gaining 6% on Friday.

Now Read This: Fear & Greed Index Moves To 'Greed' Zone As Nasdaq Record Gains For Third Straight Week